ORIC Pharmaceuticals, Inc. [●] Shares of Common Stock, par value $0.0001 per share Underwriting AgreementOric Pharmaceuticals, Inc. • November 10th, 2020 • Pharmaceutical preparations • New York
ORIC Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC (“JPM”), Citigroup Global Markets Inc. (“Citi”) and Jefferies LLC (“Jefferies”) are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
